abstract |
The present invention is in the field of medicine,nparticularly in the treatment of Type II diabetes andnobesity. More specifically, the present invention relatesnto selective β 3 receptor agonists useful in the treatment ofnType II diabetes and obesity. The invention providesncompounds and methods of treating type II diabetes andnobesity, comprising administering to a mammal in neednthereof compounds of the Formula I: |